Colesevelam Hydrochloride has 18 known drug interactions based on U.S. FDA drug labeling data. 10 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Cyclosporine, Ethinyl Estradiol, Glibenclamide. Patients taking Colesevelam Hydrochloride should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 18
- Major
- 10
- Moderate
- 6
Major (10)
- Colesevelam Hydrochloride + Cyclosporine— Colesevelam may decrease cyclosporine exposure. In vivo studies showed decreased exposure when coadministered.
- Colesevelam Hydrochloride + Ethinyl Estradiol— Colesevelam may decrease ethinyl estradiol exposure when coadministered with oral contraceptives. In vivo studies demons…
- Colesevelam Hydrochloride + Glibenclamide— Colesevelam may decrease sulfonylurea exposure. Administer glyburide 4 hours prior to colesevelam.
- Colesevelam Hydrochloride + Glimepiride— Colesevelam may decrease sulfonylurea exposure. Administer glimepiride 4 hours prior to colesevelam.
- Colesevelam Hydrochloride + Glipizide— Colesevelam may decrease sulfonylurea exposure. Administer glipizide 4 hours prior to colesevelam.
- Colesevelam Hydrochloride + Levothyroxine— In vivo studies showed decreased levothyroxine exposure. Postmarketing reports of elevated TSH in patients on thyroid ho…
- Colesevelam Hydrochloride + Norethindrone— Colesevelam may decrease norethindrone exposure when coadministered with oral contraceptives. In vivo studies demonstrat…
- Colesevelam Hydrochloride + Olmesartan Medoxomil— Colesevelam may decrease olmesartan medoxomil exposure. Administer olmesartan medoxomil 4 hours prior to colesevelam.
- Colesevelam Hydrochloride + Phenytoin— Postmarketing reports of increased seizure activity or decreased phenytoin levels in patients receiving phenytoin with c…
- Colesevelam Hydrochloride + Warfarin— Postmarketing reports of reduced INR in patients receiving warfarin. Frequent INR monitoring required during initiation …
Moderate (6)
- Colesevelam Hydrochloride + Amlodipine Besylate And Olmesartan Medoxomil— Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose.
- Colesevelam Hydrochloride + Metformin Extended Release— WELCHOL may increase exposure of metformin extended release. Monitor patients' glycemic control.
- Colesevelam Hydrochloride + Olmesartan Medoxomil / Amlodipine Besylate / Hydrochlorothiazide— Reduces systemic exposure and peak plasma concentration of olmesartan. Administer olmesartan at least 4 hours before col…
- Colesevelam Hydrochloride + Olmesartan Medoxomil And Amlodipine Besylate And Hydrochlorothiazide— Reduces systemic exposure and peak plasma concentration of olmesartan. Administer olmesartan at least 4 hours before col…
- Colesevelam Hydrochloride + Olmesartan Medoxomil And Hydrochlorothiazide— May reduce absorption of olmesartan. Administer olmesartan at least 4 hours before colesevelam hydrochloride dose.
- Colesevelam Hydrochloride + Olmesartan Medoxomil-Hydrochlorothiazide— Reduces systemic exposure and peak plasma concentration of olmesartan. Consider administering olmesartan at least 4 hour…